Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Introducing our drug development platform, cellPrism®. Customize assays using optimally sourced and processed primary cells (blood and bone marrow cells) from multiple species.
We have multi-color flow cytometry and cell sorting capabilities. In addition to looking at T cells, B cells, and NK cells, we can also examine helper T cell subsets by both surface staining and intracellular staining.
Sourced, enriched, and tested primary NK (V158+)
cells from normal donors to help facilitate antibody
research through ADCC Assays. Available for
purchase online!
We specialize in testing new compounds
for their potential to cause clinical
neutropenia, thrombocytopenia
or anemia.
From small molecules to complex biologics.
We can test a variety of compound classes
for potential hematotoxicity in our highly
predictive in vitro assay systems.
ReachBio Research Labs provides primary cell biology based contract research services and products to the drug development and life science research communities.
Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Our extensive knowledge, and use of primary cell products allows us to confidently provide high quality primary cells from bone marrow, peripheral blood and cord blood.
With expertise encompassing many aspects of primary cell biology and a special focus on hematopoietic (blood and bone marrow) primary cell systems, we work with customers and clients involved in basic research through multiple areas of pre-clinical and clinical drug development.
Our platform is extensive and includes predictive and investigative toxicology, immuno-oncology, cell bank development, antibody testing, flow cytometry/cell sorting, assay development and much more.